Chad Galderisi
Chad Galderisi publishes mostly in Cancer Research, Hematology and Molecular Biology, on topics such as Cancer Genomics and Diagnostics, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.
- World rank
- #2,885,318 of 7,710,434 ranked researchers
- Rank in United States
- #833,387 of 1,627,098
- Works
- 35
- Citations
- 376
- Citations per work
- 10.7
What does Chad Galderisi research?
Chad Galderisi's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (33%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1439.1%
- Medicine1439.1%
- Life Sciences1132.7%
- Everything else1028.2%
- 1Cancer Research21% of their works
- 2Hematology13% of their works
- 3Molecular Biology12% of their works
- 4Oncology11% of their works
- 5Radiology, Nuclear Medicine and Imaging8% of their works
- 6Pulmonary and Respiratory Medicine8% of their works
Research topics
Which keywords describe Chad Galderisi's research?
The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations and ALK Inhibitors.
- Bacterial Therapy
- Fc Receptors
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- ALK Inhibitors
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- Imatinib
- Genomic Aberrations
- EGFR Mutations
- Medical Imaging
- Radiomics
- Therapeutic Antibodies
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Targeted Therapy202 topics
- Cancer Genomics161 topic
- Mutational Signatures161 topic
- BCR-ABL81 topic
- Imatinib81 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- ALK Inhibitors41 topic
- EGFR Mutations41 topic
- Immune Checkpoint Blockade41 topic
- Medical Imaging41 topic
- PD-1 and PD-L141 topic
- Radiomics41 topic
- Fc Receptors31 topic
- Therapeutic Antibodies31 topic
- Bacterial Therapy21 topic
- Tumor Targeting21 topic
Where does Chad Galderisi work?
Chad Galderisi's main affiliation in the publication record is Intermolecular (United States), United States.
How many publications and citations does Chad Galderisi have?
OpenAlex counts 35 works and 376 citations for Chad Galderisi, an h-index of 5, ranking #2,885,318 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chad Galderisi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.